News Blog

In Neurogenetics, Hoofbeats Mean Zebras, Not Horses

In 2019, the first gene therapy treatment for a neurogenetic disease was approved for SMA. This therapy is just the beginning, and it’s marked a tipping point in genomic analysis as it reshapes the field of neurology.

On the News Blog

Penn Medicine In the News

  • Opioid Prescriptions for Eye Surgery Patients Surge

    September 19, 2019
  • A Patient in Addiction Teaches This Heart Surgeon a Surprising Lesson

    September 19, 2019
  • Can Early Breast Cancer-Detection Be Painless, Low-Cost, and Radiation-Free?

    September 17, 2019
  • Skin Protection May Offer Surprising Benefits for Overall Health

    September 15, 2019
  • Hepatitis C-Infected Kidneys Are Safe and Work as Well as Uninfected Organs, Study Finds

    September 13, 2019
  • CRISPR Gene-Editing Shows Promise as HIV Cure, Research Shows

    September 11, 2019